Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

With a test currently under FDA review, Inflammatix commences a 600 patient-strong clinical trial in emergency departments.

New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with antibody ...

HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...